Abstract:Rabies is a fatal encephalitic disease in humans and animals caused by lyssaviruses, most commonly rabies virus (RABV). Human antemortem diagnosis of rabies is a complex process involving multiple sample types and tests for the detection of antibodies, antigen (protein), and nucleic acids (genomic RNA). Serological diagnosis of human rabies includes the detection of either neutralizing or binding antibodies in the cerebrospinal fluid (CSF) or serum samples from unimmunized individuals without prior rabies vaccination or passive immunization with purified immunoglobulins. While neutralizing antibodies are targeted against the surface-expressed glycoprotein (G protein), binding antibodies to viral antigens are predominantly against the nucleoprotein (N protein), although there can be antibodies against all RABV-expressed proteins. To determine N protein-specific antibody responses in the CSF and serum during RABV infection, we developed an enzyme-linked immunosorbent assay (ELISA) with purified recombinant N protein expressed in E. coli. N protein-specific immunoglobulin (Ig) subtypes IgG and IgM were detected in the CSF or serum of previously diagnosed human rabies cases. In addition, anti-N protein seroconversion was demonstrated over the course of illness in individual rabies cases. We compared the N protein ELISA results to those of an indirect fluorescent antibody (IFA) test, the current binding antibody assay used in diagnosis, and show that our ELISA is consistent with the IFA test. Sensitivity and specificity of the N protein ELISA ranged from 78.38-100% and 75.76-96.77% with respect to the IFA results. Our data provide evidence for the use of an N protein ELISA as an additional option for the detection of RABV-specific IgG or IgM antibodies in human CSF or serum specimens.

Early Diagnosis of Rabies Virus Infection by RPA-CRISPR Techniques in a Rat Model

A recombinase polymerase amplification assay for rapid detection of rabies virus

An ELISA-based method for detection of rabies virus nucleoprotein-specific antibodies in human antemortem samples

Preexposure and Postexposure Prophylaxis of Rabies With Adeno-Associated Virus Expressing Virus-Neutralizing Antibody in Rodent Models

Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system

Establishment and application of real-time RT-PCR in detection of rabies virus

A Simple Magnetic-aided Microfluidic Screening Approach for Rabies Virus via Rolling Circle Amplification

Developing a detection method for rabies virus neutralizing antibodies using pseudotype technique

Rapid, sensitive, and visual detection of pseudorabies virus with an RPA-CRISPR/EsCas13d-based dual-readout portable platform

Development and validation of a real-time PCR assay for the diagnosis of rabies virus Philippine strain in non-brain samples

Evaluation of Monoclonal Antibody-Based Direct, Rapid Immunohistochemical Test for Rabies Diagnosis.

Development of a novel method for detection of rabies virus neutralizing antibody

Characterization and Potential Diagnostic Application of Monoclonal Antibodies Specific to Rabies Virus

Intravitam Diagnosis of Rabies in Patients with Acute Encephalitis: A Study of Two Cases

Pomegranate-Inspired Silica Nanotags Enable Sensitive Dual-Modal Detection of Rabies Virus Nucleoprotein.

Rabies Prophylactic and Treatment Options: An In Vitro Study of siRNA- and Aptamer-Based Therapeutics

Real-time detection of Seneca Valley virus by one-tube RPA-CRISPR/Cas12a assay

Design, development, and validation of a strand-specific RT-qPCR assay to differentiate replicating versus nonreplicating Rabies virus.

Binding induced isothermal amplification reaction to activate CRISPR/Cas12a for amplified electrochemiluminescence detection of rabies viral RNA via DNA nanotweezer structure switching

A Rapid and Versatile Reverse Genetic Approach and Visualization Animal Models for Emerging Zoonotic Pseudorabies Virus

Novel Approaches to the Prevention and Treatment of Rabies.